T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
Gutierrez M, Bladek P, Goksu B, Murga-Zamalloa C, Bixby D, Wilcox R.
Int J Mol Sci. 2023 Jul 28;24(15):12106. doi: 10.3390/ijms241512106.
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
Staber PB, Herling M, Bellido M, Jacobsen ED, Davids MS, Kadia TM, Shustov A, Tournilhac O, Bachy E, Zaja F, Porkka K, Hoermann G, Simonitsch-Klupp I, Haferlach C, Kubicek S, Mayerhoefer ME, Hopfinger G, Jaeger U, Dearden C.
Blood. 2019 Oct 3;134(14):1132-1143. doi: 10.1182/blood.2019000402. Epub 2019 Jul 10.
T-cell Prolymphocytic Leukemia.
Sud A, Dearden C.
Hematol Oncol Clin North Am. 2017 Apr;31(2):273-283. doi: 10.1016/j.hoc.2016.11.010.
T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches.
Colon Ramos A, Tarekegn K, Aujla A, Garcia de de Jesus K, Gupta S.
Cureus. 2021 Feb 9;13(2):e13237. doi: 10.7759/cureus.13237.
T-cell prolymphocytic leukemia: Review of an entity and its differential diagnostic considerations.
Frater JL.
Int J Lab Hematol. 2020 Jun;42 Suppl 1:90-98. doi: 10.1111/ijlh.13180.
T-cell prolymphocytic leukemia.
Dearden CE.
Med Oncol. 2006;23(1):17-22. doi: 10.1385/MO:23:1:17.
T-cell prolymphocytic leukemia.
Dearden CE.
Clin Lymphoma Myeloma. 2009;9 Suppl 3:S239-43. doi: 10.3816/CLM.2009.s.018.
Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
Sun S, Fang W.
Biomed Pharmacother. 2020 Jun;126:110107. doi: 10.1016/j.biopha.2020.110107. Epub 2020 Apr 1.
Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact.
Braun T, Dechow A, Friedrich G, Seifert M, Stachelscheid J, Herling M.
Front Oncol. 2021 Nov 19;11:775363. doi: 10.3389/fonc.2021.775363. eCollection 2021.
T-cell prolymphocytic leukemia with follicular mucinosis.
Nemoto R, Nishikawa Y, Mochida K, Amano M.
Int J Dermatol. 2023 Mar;62(3):e151-e153. doi: 10.1111/ijd.16347. Epub 2022 Jul 3.
